Advances in Immunotherapy for Transplant Oncology
Author Contributions
Funding
Conflicts of Interest
References
- Llovet, J.M.; Kelley, R.K.; Villanueva, A.; Singal, A.G.; Pikarsky, E.; Roayaie, S.; Lencioni, R.; Koike, K.; Zucman-Rossi, J.; Finn, R.S. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 2021, 7, 6. [Google Scholar] [CrossRef]
- Safarpour, A.R.; Askari, H.; Ejtehadi, F.; Azarnezhad, A.; Raeis-Abdollahi, E.; Tajbakhsh, A.; Abazari, M.F.; Tarkesh, F.; Shamsaeefar, A.; Niknam, R.; et al. Cholangiocarcinoma and liver transplantation: What we know so far? World J. Gastrointest. Pathophysiol. 2021, 12, 84–105. [Google Scholar] [CrossRef]
- Abboud, K.; Umoru, G.; Esmail, A.; Abudayyeh, A.; Murakami, N.; Al-Shamsi, H.O.; Javle, M.; Saharia, A.; Connor, A.A.; Kodali, S.; et al. Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology. Cancers 2023, 15, 1433. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Y.; Esmail, A.; Mazzaferro, V.; Abdelrahim, M. Newest Therapies for Cholangiocarcinoma: An Updated Overview of Approved Treatments with Transplant Oncology Vision. Cancers 2022, 14, 5074. [Google Scholar] [CrossRef] [PubMed]
- Skipworth, J.; Keane, M.; Pereira, S. Update on the Management of Cholangiocarcinoma. Dig. Dis. 2014, 32, 570–578. [Google Scholar] [CrossRef]
- Esmail, A.; Badheeb, M.; Alnahar, B.; Almiqlash, B.; Sakr, Y.; Khasawneh, B.; Al-Najjar, E.; Al-Rawi, H.; Abudayyeh, A.; Rayyan, Y.; et al. Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation. Cancers 2024, 16, 1946. [Google Scholar] [CrossRef]
- Abdelrahim, M.; Esmail, A.; Abudayyeh, A.; Murakami, N.; Victor, D.; Kodali, S.; Cheah, Y.L.; Simon, C.J.; Noureddin, M.; Connor, A.; et al. Transplant Oncology: An Emerging Discipline of Cancer Treatment. Cancers 2023, 15, 5337. [Google Scholar] [CrossRef]
- Mandlik, D.S.; Mandlik, S.K.; Choudhary, H.B. Immunotherapy for hepatocellular carcinoma: Current status and future perspectives. World J. Gastroenterol. 2023, 29, 1054–1075. [Google Scholar] [CrossRef]
- Borakati, A.; Froghi, F.; Bhogal, R.H.; Mavroeidis, V.K. Liver transplantation in the management of cholangiocarcinoma: Evolution and contemporary advances. World J. Gastroenterol. 2023, 29, 1969–1981. [Google Scholar] [CrossRef] [PubMed]
- Alghamdi, S.; Al-Hamoudi, W. Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology. Cancers 2023, 15, 5115. [Google Scholar] [CrossRef] [PubMed]
- Wassmer, C.-H.; El Hajji, S.; Papazarkadas, X.; Compagnon, P.; Tabrizian, P.; Lacotte, S.; Toso, C. Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data. Cancers 2023, 15, 4574. [Google Scholar] [CrossRef]
- Mazzaferro, V.M.; Regalia, E.; Doci, R.; Andreola, S.; Pulvirenti, A.; Bozzetti, F.; Montalto, F.; Ammatuna, M.; Morabito, A.; Gennari, L. Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis. N. Engl. J. Med. 1996, 334, 693–700. [Google Scholar] [CrossRef]
- Reichman, T.W.; Katchman, H.; Tanaka, T.; Greig, P.D.; McGilvray, I.D.; Cattral, M.S.; Renner, E.L.; Selzner, M.; Ghanekar, A.; Levy, G.; et al. Living donor versus deceased donor liver transplantation: A surgeon-matched comparison of recipient morbidity and outcomes. Transpl. Int. 2013, 26, 780–787. [Google Scholar] [CrossRef]
- Humar, A.; Ganesh, S.; Jorgensen, D.; Tevar, A.; Ganoza, A.; Molinari, M.; Hughes, C. Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant. Ann. Surg. 2019, 270, 444–451. [Google Scholar] [CrossRef]
- Fisher, R.A.; Cotterell, A.H.; Maluf, D.G.; Stravitz, R.T.; Ashworth, A.; Nakatsuka, M.; Sterling, R.K.; Luketic, V.A.; Behnke, M.K.; Posner, M.P. Adult living donor versus deceased donor liver transplantation: A 10-year prospective single center experience. Ann. Hepatol. 2009, 8, 298–307. [Google Scholar] [CrossRef]
- Marron, T.U.; Schwartz, M.; Corbett, V.; Merad, M. Neoadjuvant Immunotherapy for Hepatocellular Carcinoma. J. Hepatocell. Carcinoma 2022, 9, 571–581. [Google Scholar] [CrossRef]
- Zhao, M.; Chen, S.; Li, C.; Du, Y.; Li, P. Neoadjuvant Immune Checkpoint Inhibitors for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers 2023, 15, 600. [Google Scholar] [CrossRef]
- Chamseddine, S.; LaPelusa, M.; Kaseb, A.O. Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma—A Narrative Review. Cancers 2023, 15, 3508. [Google Scholar] [CrossRef]
- Rizzo, A.; Brandi, G. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review. Cancer Treat. Res. Commun. 2021, 27, 100354. [Google Scholar] [CrossRef] [PubMed]
- Ghio, M.; Vijay, A. Intrahepatic cholangiocarcinoma: Evolving role of neoadjuvant and targeted therapy. Ann. Hepato-Biliary-Pancreat. Surg. 2023, 27, 123–130. [Google Scholar] [CrossRef] [PubMed]
- (ILTS) TILTS. 2024 ILTS–ILCA Consensus Conference: Liver Transplantation for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The International Liver Transplant Society (ILTS) 2024. Available online: https://ilts.org/events/2024-ilts-ilca-consensus-conference/ (accessed on 1 June 2024).
- Yao, F.Y.; Xiao, L.; Bass, N.M.; Kerlan, R.; Ascher, N.L.; Roberts, J.P. Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF-Expanded Criteria Based on Preoperative Imaging. Am. J. Transplant. 2007, 7, 2587–2596. [Google Scholar] [CrossRef]
- Soejima, Y.; Taketomi, A.; Yoshizumi, T.; Uchiyama, H.; Aishima, S.; Terashi, T.; Shimada, M.; Maehara, Y. Extended Indication for Living Donor Liver Transplantation in Patients with Hepatocellular Carcinoma. Transplantation 2007, 83, 893–899. [Google Scholar] [CrossRef]
- Xu, X.; Lu, D.; Ling, Q.; Wei, X.; Wu, J.; Zhou, L.; Yan, S.; Wu, L.; Geng, L.; Ke, Q.; et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut 2015, 65, 1035–1041. [Google Scholar] [CrossRef]
- Abdelrahim, M.; Esmail, A.; Divatia, M.K.; Xu, J.; Kodali, S.; Victor, D.W.; Brombosz, E.; Connor, A.A.; Saharia, A.; Elaileh, A.; et al. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma. J. Clin. Med. 2024, 13, 3068. [Google Scholar] [CrossRef]
- Mehta, N.; Heimbach, J.; Harnois, D.M.; Sapisochin, G.; Dodge, J.L.; Lee, D.; Burns, J.M.; Sanchez, W.; Greig, P.D.; Grant, D.R.; et al. Validation of a Risk Estimation of Tumor Recurrence after Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence after Liver Transplant. JAMA Oncol. 2017, 3, 493–500. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Abdelrahim, M.; Esmail, A.; He, A.R.; Khushman, M.; Rayyan, Y. Advances in Immunotherapy for Transplant Oncology. Cancers 2024, 16, 2369. https://doi.org/10.3390/cancers16132369
Abdelrahim M, Esmail A, He AR, Khushman M, Rayyan Y. Advances in Immunotherapy for Transplant Oncology. Cancers. 2024; 16(13):2369. https://doi.org/10.3390/cancers16132369
Chicago/Turabian StyleAbdelrahim, Maen, Abdullah Esmail, Aiwu Ruth He, Moh’d Khushman, and Yaser Rayyan. 2024. "Advances in Immunotherapy for Transplant Oncology" Cancers 16, no. 13: 2369. https://doi.org/10.3390/cancers16132369